Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5440)
Fortrea Holdings Inc. (FTRE)
Russell Carrie Elizabeth — Interim CAO
Shares
246
Price
$16.85
Total Value
$4.15K
Shares Held After
2,384
% of Holdings
9.4%
Beta Bionics, Inc. (BBNX)
Hopman Mark — Chief Commercial Officer
Shares
36,870
Price
$18.46
Total Value
$680.72K
Shares Held After
87,157
% of Holdings
29.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$509.00
Total Value
$101.80K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
506
Price
$507.68
Total Value
$256.88K
Shares Held After
324,643
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
794
Price
$506.84
Total Value
$402.43K
Shares Held After
325,149
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
875
Price
$505.78
Total Value
$442.56K
Shares Held After
325,943
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
964
Price
$505.03
Total Value
$486.85K
Shares Held After
326,818
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,144
Price
$503.60
Total Value
$576.12K
Shares Held After
327,782
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,017
Price
$502.87
Total Value
$511.41K
Shares Held After
328,926
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
361
Price
$500.84
Total Value
$180.80K
Shares Held After
329,943
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
519
Price
$499.73
Total Value
$259.36K
Shares Held After
330,304
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$498.85
Total Value
$199.54K
Shares Held After
330,823
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$497.56
Total Value
$79.61K
Shares Held After
331,223
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,278
Price
$496.73
Total Value
$634.82K
Shares Held After
331,383
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,202
Price
$495.65
Total Value
$595.77K
Shares Held After
332,661
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$493.81
Total Value
$39.50K
Shares Held After
333,863
% of Holdings
0.0%
BRISTOL MYERS SQUIBB CO (BMY)
Massacesi Cristian — EVP,Chief Med Offr,Head of Dev
Shares
6,249
Price
$64.57
Total Value
$403.50K
Shares Held After
18,748
% of Holdings
25.0%
YD Bio Ltd (YDES)
Shen Ethan PhD — Director
Shares
3,100
Price
$3.93
Total Value
$12.18K
Shares Held After
11,245,631
% of Holdings
0.0%
Korro Bio, Inc. (KRRO)
Dolan Oliver — Senior Vice President, Finance
Shares
6
Price
$13.60
Total Value
$81.62
Shares Held After
16,246
% of Holdings
0.0%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
3,149
Price
$16.85
Total Value
$53.06K
Shares Held After
81,794
% of Holdings
3.7%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
5,836
Price
$2.09
Total Value
$12.20K
Shares Held After
2,775,229
% of Holdings
0.2%
Grace Therapeutics, Inc. (GRCE)
Kohli Prashant — Director
Shares
100,000
Price
$2.14
Total Value
$214.00K
Shares Held After
121,357
% of Holdings
82.4%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
3,097
Price
$68.70
Total Value
$212.78K
Shares Held After
536,876
% of Holdings
0.6%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
28,837
Price
$7.13
Total Value
$205.61K
Shares Held After
3,885,115
% of Holdings
0.7%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
28,837
Price
$7.13
Total Value
$205.61K
Shares Held After
3,885,115
% of Holdings
0.7%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — EVP&Chief Mfg and Supply Cha
Shares
23
Price
$350.20
Total Value
$8.05K
Shares Held After
812
% of Holdings
2.8%
Vaxcyte, Inc. (PCVX)
Wassil Jim — EVP, Chief Scientific Ofc, COO
Shares
1,334
Price
$59.52
Total Value
$79.40K
Shares Held After
145,435
% of Holdings
0.9%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
36,000
Price
$97.78
Total Value
$3.52M
Shares Held After
708,709
% of Holdings
4.8%
Jushi Holdings Inc. (JUSH)
Arsenault Denis J. — 10% Owner
Shares
15,100
Price
$0.62
Total Value
$9.36K
Shares Held After
7,811,033
% of Holdings
0.2%
Tenon Medical, Inc. (TNON)
HRT FINANCIAL LP — 10% Owner
Shares
707
Price
$3.34
Total Value
$2.36K
Shares Held After
2,653
% of Holdings
26.6%
KAMADA LTD (KMDA)
Tsur David — Director
Shares
162,760
Price
$8.26
Total Value
$1.34M
Shares Held After
430,931
% of Holdings
27.4%
CYBIN INC. (CYBN)
So Eric H. L. — Director
Shares
100,000
Price
$12.39
Total Value
$1.24M
Shares Held After
4,465,014
% of Holdings
2.2%
CYBIN INC. (CYBN)
Glavine Paul — Chief Growth Officer
Shares
100,000
Price
$12.47
Total Value
$1.25M
Shares Held After
4,271,252
% of Holdings
2.3%
CYBIN INC. (CYBN)
Glavine Paul — Chief Growth Officer
Shares
100,000
Price
$12.47
Total Value
$1.25M
Shares Held After
4,271,252
% of Holdings
2.3%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
54,174
Price
$145.87
Total Value
$7.90M
Shares Held After
522,968
% of Holdings
9.4%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Schwartz Jeffrey Lawrence — Director
Shares
3,890
Price
$25.18
Total Value
$97.94K
Shares Held After
7,019
% of Holdings
35.7%
Roivant Sciences Ltd. (ROIV)
Fitzgerald Meghan — Director
Shares
20,000
Price
$39.90
Total Value
$798.00K
Shares Held After
42,963
% of Holdings
31.8%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Ladone Mary Kay — Director
Shares
3,908
Price
$25.20
Total Value
$98.46K
Shares Held After
37,507
% of Holdings
9.4%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Hanley Conor — Director
Shares
5,694
Price
$25.25
Total Value
$143.78K
Shares Held After
6,272
% of Holdings
47.6%
Ceribell, Inc. (CBLL)
Foehr David — Senior VP, Finance and PAO
Shares
7,500
Price
$24.25
Total Value
$181.88K
Shares Held After
34,144
% of Holdings
18.0%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Reilly Kevin C — Director
Shares
2,932
Price
$25.13
Total Value
$73.68K
Shares Held After
5,368
% of Holdings
35.3%
Ceribell, Inc. (CBLL)
Foehr David — Senior VP, Finance and PAO
Shares
1,755
Price
$24.26
Total Value
$42.58K
Shares Held After
34,144
% of Holdings
4.9%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
4,887
Price
$24.33
Total Value
$118.90K
Shares Held After
203,118
% of Holdings
2.3%
BillionToOne, Inc. (BLLN)
Lynch Thomas P. — General Counsel, Chief Compliance Officer and Secretary
Shares
232
Price
$100.92
Total Value
$23.41K
Shares Held After
700
% of Holdings
24.9%
BillionToOne, Inc. (BLLN)
Lynch Thomas P. — General Counsel, Chief Compliance Officer and Secretary
Shares
2,518
Price
$100.20
Total Value
$252.29K
Shares Held After
932
% of Holdings
73.0%
BillionToOne, Inc. (BLLN)
Lynch Thomas P. — General Counsel, Chief Compliance Officer and Secretary
Shares
576
Price
$98.89
Total Value
$56.96K
Shares Held After
3,450
% of Holdings
14.3%
BillionToOne, Inc. (BLLN)
Lynch Thomas P. — General Counsel, Chief Compliance Officer and Secretary
Shares
147
Price
$101.41
Total Value
$14.91K
Shares Held After
4,026
% of Holdings
3.5%
BillionToOne, Inc. (BLLN)
Lynch Thomas P. — General Counsel, Chief Compliance Officer and Secretary
Shares
1,131
Price
$100.33
Total Value
$113.47K
Shares Held After
4,173
% of Holdings
21.3%
BillionToOne, Inc. (BLLN)
Lynch Thomas P. — General Counsel, Chief Compliance Officer and Secretary
Shares
385
Price
$99.22
Total Value
$38.20K
Shares Held After
5,304
% of Holdings
6.8%
BillionToOne, Inc. (BLLN)
Lynch Thomas P. — General Counsel, Chief Compliance Officer and Secretary
Shares
358
Price
$100.82
Total Value
$36.09K
Shares Held After
5,689
% of Holdings
5.9%
Showing 351–400 of 5440 transactions (page 8 of 109)